"poster presentation on CHECKvacc which was trialed in mTNBC. Will be interested to see this one and who presents it".
Hi GMT2, it is my understanding that Imugene allowed Yuman Fong to continue with his TNBC study, treating patients only at their City of Hope site, at the COH expense and under the study supervision of Dr Rand. Yuman Fong was passionate about this terrible cancer, as there were few treatments available for patients. He also mentioned in the July 2023 roadshow, that the Vaxinia MAST study is more potent than the CHECKvacc TNBC study.
Regards.
IMU Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)